Panitumumab activity in metastatic colorectal cancer patients with ≥10% epidermal growth factor receptor levels

被引：0
|
作者：
Chan, E.
Neubauer, M.
Swanson, P.
Harker, W.
Burris, H.
Hecht, J.
Navale, L.
Brown, J.
Amado, R.
机构：
[1] Vanderbilt Univ Sch Med, Nashville, TN USA
[2] Kansas City Canc Ctr, Overland Pk, KS USA
[3] Hematol Oncol Associates, Port St Lucie, FL USA
[4] Utah Canc Specialists, Salt Lake City, UT USA
[5] Tennessee Oncol, Nashville, TN USA
[6] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
[7] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [1] Panitumumab in metastatic colorectal cancer patients with low/negative epidermal growth factor receptor levels
    Mitchell, E.
    Hecht, J.
    Baranda, J.
    Malik, I
    Richards, D.
    Navale, L.
    D'Avirro, P.
    Amado, R.
    ANNALS OF ONCOLOGY, 2006, 17 : 29 - 29
  • [2] Panitumumab antitumor activity in patients (pts) with metastatic colorectal cancer (mCRC) expressing ≥ 10% epidermal growth factor receptor (EGFr).
    Berlin, J.
    Neubauer, M.
    Swanson, P.
    Harker, W. G.
    Burris, H.
    Hecht, J. R.
    Navale, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 158S - 158S
  • [3] Panitumumab and inhibition of the epidermal growth factor receptor signaling in the treatment of metastatic colorectal cancer
    Wyrwicz, Lucjan S.
    Nowecki, Zbigniew I.
    ONCOLOGY IN CLINICAL PRACTICE, 2010, 6 (06): : 290 - 300
  • [4] Panitumumab activity in metastatic colorectal cancer (mCRC) patients (pts) with low or negative tumor epidermal growth factor receptor (EGFr) levels: An updated analysis
    Mitchell, E. P.
    Hecht, J. R.
    Baranda, J.
    Malik, I.
    Richards, D.
    Reiner, M.
    Stout, S.
    Amado, R. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Epidermal Growth Factor Receptor-Targeted Therapy of Colorectal Cancer with Panitumumab
    Sartore-Bianchi, Andrea
    Sporchia, Andrea
    Cerea, Giulio
    Maugeri, Maria Rosaria
    Cipani, Tiziana
    Andreotti, Ines
    Marrapese, Giovanna
    Artale, Salvatore
    Siena, Salvatore
    CURRENT CANCER THERAPY REVIEWS, 2007, 3 (04) : 249 - 254
  • [6] Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab
    Sartore-Bianchi, Andrea
    Moroni, Mauro
    Veronese, Silvio
    Carnaghi, Carlo
    Bajetta, Emilio
    Luppi, Gabriele
    Sobrero, Alberto
    Barone, Carlo
    Cascinu, Stefano
    Colucci, Giuseppe
    Cortesi, Enrico
    Nichelatti, Michele
    Gambacorta, Marcello
    Siena, Salvatore
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) : 3238 - 3245
  • [7] Lack of Correlation between Epidermal Growth Factor Receptor Status and Response to Panitumumab Monotherapy in Metastatic Colorectal Cancer
    Hecht, J. Randolph
    Mitchell, Edith
    Neubauer, Marcus A.
    Burris, Howard A., III
    Swanson, Paul
    Lopez, Timothy
    Buchanan, Glenn
    Reiner, Maureen
    Gansert, Jennifer
    Berlin, Jordan
    CLINICAL CANCER RESEARCH, 2010, 16 (07) : 2205 - 2213
  • [8] Targeting the epidermal growth factor receptor in metastatic colorectal cancer
    Ng, Kimmie
    Zhu, Andrew X.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 65 (01) : 8 - 20
  • [9] Panitumumab antitumor activity in patients (pts) with metastatic colorectal cancer (mCRC) expressing low (1-9%) or negative (<1%) levels of epidermal growth factor receptor (EGFr).
    Hecht, J.
    Mitchell, E.
    Baranda, J.
    Malik, I.
    Richards, D.
    Navale, L.
    D'Avirro, P.
    Amado, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 157S - 157S
  • [10] Epidermal growth factor receptor and epidermal growth factor receptor variant III gene expression in metastatic colorectal cancer
    Azuma, Mizutomo
    Danenberg, Kathleen D.
    Iqbal, Syma
    El-Khoueiry, Anthony
    Zhang, Wu
    Yang, Dongyun
    Koizumi, Wasaburo
    Saigenji, Katsunori
    Danenberg, Peter V.
    Lenz, Heinz-Josef
    CLINICAL COLORECTAL CANCER, 2006, 6 (03) : 214 - 218
12345